Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion type Assertion NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_head.
- NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion description "[As an inhibitor of AKT2, miR-184 could be of potential benefit in miRNA mediated therapeutics of MYCN amplified neuroblastoma and other forms of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_provenance.
- NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion evidence source_evidence_literature NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_provenance.
- NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion SIO_000772 20409325 NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_provenance.
- NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion wasDerivedFrom befree-2016 NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_provenance.
- NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_assertion wasGeneratedBy ECO_0000203 NP807427.RAxoU_JZtsPw03mzEwbYnR1cGDr9eHX8u-3LlIZ-gWDt4130_provenance.